Initial Results from a Phase 1a/1b Study of STK-012, a First-in-class Α/β IL-2 Receptor Biased Partial Agonist in Advanced Solid Tumors (NCT05098132)
Benjamin Izar,Dmitriy Zamarin,David R. Spigel, Christopher J. Hoimes,David F. McDermott,Kartik Sehgal,Yana G. Najjar,Adam J. Schoenfeld,Edward B. Garon,Ryan J. Sullivan,Brian S. Henick,Ticiana A. Leal,Michael E. Hurwitz,Rana R. McKay,Natalie Busby,Anita Mehta-Damani,Alex Azrilevich,Tony Tran,Naiyer Rizvi,Martin Oft,Alexander I. Spira CANCER RESEARCH（2024）
AI 理解论文
溯源树
样例
